Amarin Corp Plc (AMRN) Posts Q1 Loss of 16c/Share; Updates on Ops
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Second-Half Vascepa Sales Growth Still in Focus for Amarin (AMRN); Aegis Maintains at 'Hold'
May 12, 2014 9:31 AM EDTAegis Capital maintains its Hold rating and $2 price target on Amarin Corp. (Nasdaq: AMRN) following Q1 results reported last week.
Analyst Ram Selvaraju Vascepa sales came in lighter than expected at $1.1 million, though R&D expenses of $11.7 million compared with the analysts... More
UPDATE: Citi Downgrades Amarin Corporation (AMRN) to Neutral
May 12, 2014 6:42 AM EDT(Updated - May 12, 2014 10:07 AM EDT)
Citi downgraded Amarin Corporation (NASDAQ: AMRN) from Buy to Neutral with a price target of $1.75. Analyst Jonathan Eckard thinks shares will trade range-bound near-term.
"We are downgrading AMRN to Neutral from Buy, finding it harder to see when Vascepa sales could turn a corner to drive support back to the stock. Dragging sales... More
